Skip to main content
Midas Edge

GeneDx Holdings Corp

For the period ended Dec 31, 2023. Filed Feb 23, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 23, 2024

WGS$65.72+5.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
Cautionary Note Regarding Forward Looking Statements3
PART I
Item 1. Business4
Item 1A. Risk Factors19
Item 1B. Unresolved Staff Comments56
Item 1C. Cybersecurity56
Item 2. Properties57
Item 3. Legal Proceedings57
Item 4. Mine Safety Disclosures57
PART II
Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities58
Item 6. Reserved58
Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations59
Item 7A. Quantitative and Qualitative Disclosures About Market Risk70
Item 8. Financial Statements and Supplementary Data70
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosures107
Item 9A. Controls and Procedures107
Item 9B. Other Information109
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections109
PART III
Item 10. Directors, Executive Officers and Corporate Governance110
Item 11. Executive Compensation110
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters110
Item 13. Certain Relationships and Related Transactions, and Director Independence110
Item 14. Principal Accounting Fees and Services110
PART IV
Item 15. Exhibits, Financial Statement Schedules111
Signatures115
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.